CD8A and COVID-19: M Fernández-Ruiz et al. reported a persistent T cell immunity (CD4+ and CD8+ T cells) reactive to the S1 subunit for at least 6 months in 21 kidney transplant recipients recovered from moderate to severe COVID-19 [28].